Skip to main content

Investing Automations AI Videos Calculators

Investing
Automations
AI
Videos
Calculators
Log In

Loading…

AI | Automation | Investing

Explore

AI
Automation
Investing
Videos
Calculators
Guest Post

Account

Register
Log In
Account
Contact

Policies

Privacy Policy
Cookie Policy
Terms of Use
Accessibility
Financial Disclaimer

© 2026 Joshua Thompson. All rights reserved.Anything shared here reflects personal opinion and is not financial advice.

Loading…

Poolbeg Pharma PLC | Joshua Thompson

The Archive · 2 posts

Poolbeg Pharma PLC

Discover new possibilities in health with Poolbeg Pharma (POLB) – pioneering infectious disease treatments and listed on the LSE. 💡

Share price

8 Jul 2026 @ 17:00

Poolbeg Pharma PLC

LON:POLB · XLON

Latest close

7.10p

+0.20p (+2.90%)

1M -10.13%

Open: 6.95p
High: 7.18p
Low: 6.80p
Volume: 280.1K

Last updated: 8 Jul 2026 @ 17:00

SubscribeRSS JSON

Join the newsletter

It'd be great to have you 🤝

Email address

I consent to marketing from JT *

Search Investing

Economic Trends Investing Basics Investment Analysis Investment News Personal Finance

Poolbeg Pharma Reports Full Year 2025 Results and Key Progress on POLB 001 Clinical Trial

Poolbeg Pharma reports FY25 results with POLB 001 trial progress, cash runway to 2027, and interim data expected this summer.

Browse All

Sort posts

Showing 1 of 2 posts

Investing

Poolbeg Pharma Targets $10B Market with POLB 001 Phase 2 Trial and Advances Oral GLP-1 Programme

Poolbeg Pharma's POLB 001 Phase 2 in cancer immunotherapy & oral GLP-1 for obesity. AI pipeline, Friel's leadership & 2026 catalysts analysed.

JoshuaMay 20, 2025

Get the latest Investment news

Email address

I consent to marketing from JT *

Got an investment you want to share?

April 28, 2026

Search Investing

What's new?

Investing
Poolbeg Pharma Targets $10B Market with POLB 001 Phase 2 Trial and Advances Oral GLP-1 Programme
May 20, 2025

Trending_